West Family Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Buy
9,435
+2,812
+42% +$121K 0.13% 210
2026
Q1
$243K Sell
6,623
-12,048
-65% -$571K 0.09% 210
2025
Q4
$950K Sell
18,671
-3,041
-14% -$156K 0.22% 88
2025
Q3
$1.2M Buy
21,712
+350
+2% +$20.5K 0.27% 79
2025
Q2
$1.47M Buy
21,362
+5,491
+35% +$373K 0.38% 45
2025
Q1
$1.1M Sell
15,871
-4,502
-22% -$372K 0.42% 47
2024
Q4
$1.75M Sell
20,373
-488
-2% -$52.8K 0.61% 26
2024
Q3
$2.48M Buy
20,861
+601
+3% +$80.2K 0.85% 18
2024
Q2
$2.89M Sell
20,260
-1,895
-9% -$251K 0.87% 29
2024
Q1
$2.84M Sell
22,155
-2,175
-9% -$259K 0.88% 28
2023
Q4
$2.52M Sell
24,330
-388
-2% -$38.4K 0.85% 29
2023
Q3
$2.25M Sell
24,718
-2,510
-9% -$221K 0.78% 29
2023
Q2
$2.2M Buy
27,228
+444
+2% +$36.3K 0.86% 25
2023
Q1
$2.13M Hold
26,784
0.84% 26
2022
Q4
$1.81M Sell
26,784
-1,132
-4% -$66.4K 0.62% 32
2022
Q3
$1.39M Sell
27,916
-68
-0.2% -$3.64K 0.58% 36
2022
Q2
$1.56M Sell
27,984
-3,224
-10% -$179K 0.61% 34
2022
Q1
$1.73M Hold
31,208
0.49% 37
2021
Q4
$1.75M Sell
31,208
-3,354
-10% -$182K 0.48% 36
2021
Q3
$1.66M Buy
34,562
+1,556
+5% +$75.2K 0.43% 37
2021
Q2
$1.38M Buy
+33,006
New +$1.28M 0.37% 42

Other funds holding NVO

West Family Investments's NVO Position: Q2 2026 in Review

West Family Investments increased its Novo Nordisk (NVO) stake by 42% in Q2 2026, buying an estimated $121K and bringing the position to 9,435 shares worth $452K. The position accounts for 0.13% of the portfolio, ranked #210.

West Family Investments first reported a position in NVO in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.89M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • West Family Investments held 9,435 shares of Novo Nordisk worth $452K as of Q2 2026.
  • West Family Investments bought 2,812 Novo Nordisk shares in Q2 2026, an estimated $121K.
  • Novo Nordisk made up 0.13% of West Family Investments's portfolio in Q2 2026, its #210 holding.
  • West Family Investments first reported a position in Novo Nordisk in Q2 2021 and has held it in 21 quarters since.
  • West Family Investments's Novo Nordisk position peaked at $2.89M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.